Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Recognition of Distinction Awards 2020

Awards and Honours Strategic Developments

It is a great pleasure to announce that a number of Neuroscience researchers have been successful in the recent assessment process for the conferment of the title of full Professor.

Ambitious Oxford initiative launched to address graduate under-representation

Strategic Developments

Oxford University and its colleges have announced a major new scholarship scheme for black graduate students as part of a programme to transform its graduate population by creating more funding opportunities for under-represented groups.

Einstein Visiting Fellowship awarded to Zoltán Molnár

Awards and Honours Strategic Developments

Professor Zoltán Molnár has been awarded an Einstein Visiting Fellowship to Charité - University Medicine, Berlin. This award sees him join the dynamic Oxford | Berlin collaboration, a strategic research partnership that supports high quality joint research initiatives across all disciplines of its member institutions, of which Neuroscience is a major focus.

First of its kind in UK - Innovative New Brain Health Centre

Strategic Developments

New Oxford Brain Health Centre (BHC) open. Developed with the involvement of members of the public with lived experience of memory problems, the centre is a combined clinical and research service which has the potential to revolutionise NHS memory services.

Irene Tracey voted FENS President-Elect

Awards and Honours Strategic Developments

The British Neuroscience Association is delighted to congratulate Irene Tracey as the new President-Elect for the Federation of European Neuroscience Societies

NDCN awarded Athena SWAN Silver Renewal

Awards and Honours Strategic Developments

NDCN has been awarded a renewal of its Athena SWAN Silver Award. This award is a strong endorsement of NDCN’s work to improve gender equality and build a positive research culture.

Professor Fran Platt appointed as new Head of Department of Pharmacology

Strategic Developments

Professor Fran Platt has been appointed as the new Head of Department for Pharmacology at the University of Oxford. Fran took up her new post with effect from 1 June 2020 and will serve for an initial period of five years.

University of Oxford joins the European Universities Initiative

Strategic Developments

The European Commission has recognised an alliance of Oxford University and seven other universities to join ‘European Universities Initiative’. The programme will receive 5 million euros for the next three years. The programme will focus on neurosciences and technology - to begin with.

New OXCADAT Guidance and Resources to Help Patients Cope with Trauma after Intensive Care

Strategic Developments

New OXCADAT guidance and resources to help patients cope with trauma after intensive care

Wolfson Building housing stroke centre opens

Strategic Developments

Research into strokes and vascular dementia took a major step forward on Thursday 5 March with the official opening of our Wolfson Centre for the Prevention of Stroke and Dementia (CPSD) based at the new Wolfson Building.

NDCN welcomes the MRC Brain Network Dynamics Unit

Strategic Developments

We are pleased to announce that the University of Oxford MRC Brain Network Dynamics Unit joins the Nuffield Department of Clinical Neurosciences (NDCN) as a sixth division.

NHS staff across England get free access to wellbeing apps

Strategic Developments

NHS England has announced a programme to provide NHS staff with evidence-based digital programmes to protect their mental health during the COVID-19 response. The apps are designed to help maintain healthy sleep, and reduce anxiety.

New Oxford Brain Health Clinical Trials Unit Open

Strategic Developments

A new Clinical Trials Unit has opened within the Department of Psychiatry - the Oxford Brain Health Clinical Trials Unit - it is the only mental health-dedicated Clinical Trials Unit in the UK. It opened in September 2019 and has replaced the former Oxford Cognitive Health and Neuroscience Clinical Trials Unit.

Oxford is joint top recruiter to drug-resitant epilepsy study

Research Highlights Strategic Developments

The Oxford Epilepsy Research Group is at the forefront of some potentially ground-breaking work with patients who have drug-resistant epilepsy. Epilepsy affects over 50 million people worldwide and nearly one in three people with epilepsy are resistant to current drugs.

Pathways to Mental Health and Academic Outcomes

Strategic Developments

The Oxford U-Flourish student wellbeing survey is part of a longitudinal study evaluating the scope of mental health need among undergraduate students. The study aims to better understand what factors determine student mental health and academic outcomes.

Building quality, diversity and publicity for mental health research

Strategic Developments

In a move that will transform future mental health research, Prof Elaine Fox has been made the national Mental Health Impact and Engagement Coordinator for UK Research and Innovation. Read more to find out more about what this means for supporting improved mental health research across the UK.

Oxford Short Course in Experimental Medicine for Mental Health - OxCEMM

Events Strategic Developments

This new course ran for the first time in January 2019, with an engaging and thought-provoking programme of talks, tours of facilities and group discussions. Feedback from participants was uniformly excellent. Applications for the January 2020 course opened on 15th August 2019.

Load More